Abstract:The clustered regularly interspaced short palindromic repeat (CRISPR)-Cas12a system is a powerful tool in gene editing; however, crRNA-DNA mismatches might induce unwanted cleavage events, especially at the distal end of the PAM. To minimize this limitation, we engineered a hyper fidelity AsCas12a variant carrying the mutations S186A/R301A/T315A/Q1014A/K414A (termed HyperFi-As) by modifying amino acid residues interacting with the target DNA and crRNA strand. HyperFi-As retains on-target activities comparable to wild-type AsCas12a (AsCas12aWT) in human cells. We demonstrated that HyperFi-As has dramatically reduced off-target effects in human cells, and HyperFi-As possessed notably a lower tolerance to mismatch at the position of the PAM-distal region compared with the wild type. Further, a modified single-molecule DNA unzipping assay at proper constant force was applied to evaluate the stability and transient stages of the CRISPR/Cas ribonucleoprotein (RNP) complex. Multiple states were sensitively detected during the disassembly of the DNA-Cas12a-crRNA complexes. On off-target DNA substrates, the HyperFi-As-crRNA was harder to maintain the R-loop complex state compared to the AsCas12aWT, which could explain exactly why the HyperFi-As has low off-targeting effects in human cells. Our findings provide a novel version of AsCas12a variant with low off-target effects, especially capable of dealing with the high off-targeting in the distal region from the PAM. An insight into how the AsCas12a variant behaves at off-target sites was also revealed at the single-molecule level and the unzipping assay to evaluate multiple states of CRISPR/Cas RNP complexes might be greatly helpful for a deep understanding of how CRISPR/Cas behaves and how to engineer it in future.

Molecular Basis and Engineering of Miniature Cas12f with C-rich PAM Specificity

Programmed genome editing by a miniature CRISPR-Cas12f nuclease

Expanding the CRISPR toolbox by engineering Cas12a orthologs of metagenomic discovery

DNA targeting by compact Cas9d and its resurrected ancestor

PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage

Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3

Structure of the miniature type V-F CRISPR-Cas effector enzyme

The Compact Casπ (cas12l) ‘bracelet’ Provides a Unique Structural Platform for DNA Manipulation

Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system

Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing

Discovery and engineering of ChCas12b for precise genome editing

Engineering of Cas12a nuclease variants with enhanced genome-editing specificity

Structure and genome editing activity of the novel CRISPR-Cas12o1 effector

Advances in miniature CRISPR-Cas proteins and their applications in gene editing

Genome editing with natural and engineered CjCas9 orthologs

Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing

An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants

Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing

High-Throughput Profiling of Cas12a Orthologues and Engineered Variants for Enhanced Genome Editing Activity

Cas12n nucleases, early evolutionary intermediates of type V CRISPR, comprise a distinct family of miniature genome editors